Numans Health Food Holdings Announces Possible Major Disposal of Lenovo Group Shares
Key Highlights
- Disposal Mandate Approved: Numans Health Food Holdings Company Limited has obtained written approval from its controlling shareholder, Far-East Fortune Management (China) Co., Ltd., for a mandate to dispose of up to all Lenovo Group shares held by the Group over a 12-month period.
- Potential Major Transaction: The disposal, when aggregated with previous Lenovo Group share disposals, could exceed 25% but less than 75% of relevant percentage ratios under Hong Kong Listing Rules, constituting a major transaction subject to reporting, announcement, circular, and shareholder approval requirements.
- Shares Held and to be Disposed: As of the announcement date, Numans Health Food Holdings holds 4,000,000 Lenovo Group shares, representing approximately 0.03% of Lenovo Group’s total issued share capital.
- Previous Disposals: In the preceding 12 months, the Company disposed of 6,000,000 Lenovo Group shares, which were classified as discloseable transactions.
- Disposal Method: Shares will be sold through the open market on the Hong Kong Stock Exchange at prevailing market prices, without prior approval needed for each batch, to maximize returns and flexibility.
- Usage of Proceeds: Proceeds from the disposals will be used for general working capital, enhancing liquidity for Numans Health Food Holdings.
- No General Meeting Required: Written approval replaces the need for a shareholder meeting, pursuant to Rule 14.44 of the Listing Rules.
- Reporting Commitment: Progress of disposals will be disclosed in interim and annual reports in compliance with Listing Rules.
- Lenovo Group Profile: Lenovo Group is a major Hong Kong-listed technology company, with US\$83,075 million revenue and US\$2,160 million profit for the year ended 31 March 2026.
- Company Profile: Numans Health Food Holdings is focused on investment holding and the marketing/sale of nutritional products in China under proprietary brands, including algal oil DHA, probiotics, vitamins, multi-nutrients, and algal calcium products.
- Mandate Period: The disposal mandate lasts for 12 months from the approval date.
- Potential Share Price Impact: The announcement signals a substantial reduction in Numans’s holding of Lenovo Group shares, potentially affecting both companies’ share prices. Investors should note the flexibility and market-dependent nature of the disposal pricing.
Details for Shareholders and Investors
This announcement is significant for shareholders as it authorizes the Board to dispose of all remaining Lenovo Group shares held by Numans Health Food Holdings in the open market, enabling swift action in response to market conditions. The disposal could be price-sensitive, given the potential scale and market impact. Shareholders are not required to abstain from voting, and no extraordinary general meeting will be convened due to the written approval by the controlling shareholder.
The disposal mandate is intended to maximize returns and liquidity, with proceeds used for general working capital. The flexibility to execute disposals at favorable times and prices could materially impact Numans Health Food Holdings’ financial position and share value, as well as potentially influence Lenovo Group’s stock due to the volume being sold.
The announcement also provides transparency on previous disposals, outlines compliance requirements, and ensures ongoing reporting to shareholders.
A circular with further details is scheduled for dispatch to shareholders on or before 16 June 2026.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult their financial advisors before making any investment decisions. The actual disposal price may vary based on market conditions, and future disposals could materially affect the share price of both Numans Health Food Holdings and Lenovo Group.
紐曼思健康食品控股宣布可能重大出售聯想集團股份
重點摘要
- 出售授權獲批： 紐曼思健康食品控股有限公司已獲控股股東遠東財富管理（中國）有限公司書面批准，在未來12個月內可出售集團持有的全部聯想集團股份。
- 潛在重大交易： 此次出售與過去的聯想集團股份出售合計，比例可能超過25%但少於75%，構成重大交易，需遵守香港上市規則的報告、公告、通函和股東批准要求。
- 持股及出售股份： 截至公告日，紐曼思持有4,000,000股聯想集團股份，約佔聯想集團已發行股份總數的0.03%。
- 過去出售記錄： 過去12個月，公司已出售6,000,000股聯想集團股份，屬於可披露交易。
- 出售方式： 股份將通過香港交易所公開市場按當時市價出售，無需每次批次事前批准，以提高回報及靈活性。
- 資金用途： 出售所得將用於公司的一般營運資金，增強流動性。
- 無需股東大會： 書面批准取代股東大會，符合上市規則14.44條。
- 報告承諾： 出售進程將在中期及年度報告中披露，遵守上市規則。
- 聯想集團簡介： 聯想集團為香港上市科技公司，2026財年收入達US\$83,075百萬，利潤為US\$2,160百萬。
- 公司簡介： 紐曼思健康食品控股主要從事投資控股及中國營養產品的市場銷售，品牌包括藻油DHA、益生菌、維生素、多元營養及藻鈣產品。
- 授權期限： 授權期為批准日起12個月。
- 潛在股價影響： 公告表明紐曼思將大幅減持聯想集團股份，可能影響兩家公司股價。投資者需注意出售價格將根據市況變動，具備一定敏感性。
股東及投資者須知
此公告重大，授權董事會可於公開市場出售全數聯想集團股份，能迅速響應市場情況。出售規模可能具價格敏感性，股東無需棄權投票，亦無需召開特別股東大會，因控股股東已書面批准。
此次出售旨在提升流動資金與回報，並將靈活把握出售時機與價格，對紐曼思健康食品控股的財務狀況及股價可能產生實質影響，亦可能影響聯想集團股價。
公告同時透明披露過往出售記錄、合規要求，並承諾持續向股東報告進展。
詳細通函預計於2026年6月16日或之前寄發予股東。
免責聲明
本文僅供參考，不構成投資建議。投資者應自行做足功課，並諮詢專業財務顧問後再作投資決策。實際出售價格將視市況而定，未來出售或對紐曼思健康食品控股及聯想集團股價產生重大影響。
